Nathalie Scholler Penn Ovarian Cancer Research Center, Center for Research on Reproduction and Womans Health, Department of Obstetrics and Gynecology University of Pennsylvania-School of Medicine Biography Publications Institution JoVE Articles Nathalie Scholler has not added a biography. If you are Nathalie Scholler and would like to personalize this page please email our Author Liaison for assistance. Publications 通过使用一种新型的 T 细胞抗原受体的肿瘤过继免疫治疗普遍战略。 Cancer Research. Feb, 2012 | Pubmed ID: 22315351 肿瘤治疗妇科恶性肿瘤的生物标志。 Frontiers in Bioscience (Elite Edition). 2012 | Pubmed ID: 22201939 血清 HE4 与肿瘤大小和肌层浸润的子宫内膜癌的相关性。 Gynecologic Oncology. Feb, 2012 | Pubmed ID: 22037318 甘露糖受体 (MR) 参与由 Mesothelin GPI 锚极化肿瘤相关巨噬细胞和 Anti-MR 人类基因工程抗体被阻止。 PloS One. 2011 | Pubmed ID: 22163010 重定向主要淋巴细胞完全人类抗 Mesothelin 嵌合体转染抗肿瘤作用。 Molecular Therapy : the Journal of the American Society of Gene Therapy. Nov, 2011 | Pubmed ID: 22127019 HE4 卵巢上皮癌的多式联运筛查中的潜在作用。 Journal of the National Cancer Institute. Nov, 2011 | Pubmed ID: 21917606 新型地面目标和从卵巢癌血管的血清标志物。 Cancer Biology & Therapy. Aug, 2011 | Pubmed ID: 21617380 评价早期诊断标志物的框架: 卵巢癌生物标志板的验证。 Cancer Prevention Research (Philadelphia, Pa.). Mar, 2011 | Pubmed ID: 21372037 卵巢癌生物标志物在前列腺癌、 肺癌、 大肠癌、 和卵巢癌筛查试验标本的性能。 Cancer Prevention Research (Philadelphia, Pa.). Mar, 2011 | Pubmed ID: 21372036 高亲和力抗肿瘤血管标志使用成对的酵母-显示/分泌抗体库平台的 Endosialin/TEM1 人类抗体的快速分离。 Journal of Immunological Methods. Jan, 2011 | Pubmed ID: 20837020 评估前置重叠时间为所选的卵巢癌生物标志: 嵌套的病例对照研究。 Journal of the National Cancer Institute. Jan, 2010 | Pubmed ID: 20042715 使用预测卵巢癌症状指数、 癌抗原 125 和 HE4。 Gynecologic Oncology. Mar, 2010 | Pubmed ID: 19945742 防污表面层的基于粒子的免疫从信号到噪声改进。 Langmuir : the ACS Journal of Surfaces and Colloids. Dec, 2009 | Pubmed ID: 19928944 超越癌抗原 125: 卵巢癌生物标志物的时代的到来。还有我们尚未吗? Biomarkers in Medicine. Jun, 2009 | Pubmed ID: 19684876 诊断性能的血清标志物 Mesothelin、 HE4 和癌抗原 125 对卵巢癌的风险状况的影响。 Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. May, 2009 | Pubmed ID: 19423517 肿瘤标志物 — — 第二届 GTCbio 年会。疾病检测和治疗监测的生物标志。19-20 2009 年 1 月美国佛罗里达州迈阿密。 IDrugs : the Investigational Drugs Journal. Apr, 2009 | Pubmed ID: 19350459 孕产妇死亡率从系统性疾病: 解开对免疫反应的贡献。 American Journal of Obstetrics and Gynecology. Apr, 2009 | Pubmed ID: 19318152 对血清癌抗原 125、 Mesothelin 和 HE4 个人特征的影响各级健康绝经后妇女卵巢癌的高风险地区。 Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. Sep, 2008 | Pubmed ID: 18768519 使用特定癌症的酵母分泌的体内素重组抗体的血清标记物的发现。 Journal of Translational Medicine. 2008 | Pubmed ID: 18652693 结合 CA 125,改善检测卵巢癌症状指数。 Cancer. Aug, 2008 | Pubmed ID: 18615684 候选人血液检测卵巢癌的标记系统的评价。 PloS One. 2008 | Pubmed ID: 18612378 人类血浆蛋白质组变化与胰腺肿瘤发展相关搜索鼠标。 PLoS Medicine. Jun, 2008 | Pubmed ID: 18547137 酵母分泌的体内素重组抗体 (Biobodies) 在基于纳米磁珠技术酶联免疫吸附试验中的使用。 Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. May, 2008 | Pubmed ID: 18451228 卵巢癌癌抗原 125。 Biomarkers in Medicine. Dec, 2007 | Pubmed ID: 20477371 利用高密度抗体阵列,以验证和发现癌症血清标志物。 Molecular Oncology. Dec, 2007 | Pubmed ID: 19383305 发展和防止癌抗原 125 Mesothelin 无关的抗 Mesothelin Biobodies 体外验证单元格附件。 Cancer Letters. Oct, 2007 | Pubmed ID: 17560019 作为筛查工具的生物制品发现癌抗原 125 Mesothelin 细胞粘附的发展。 Cancer Letters. Mar, 2007 | Pubmed ID: 16677756 生成素体内重组抗体的酵母交配的方法。 Journal of Immunological Methods. Dec, 2006 | Pubmed ID: 17113097 基于纳米磁珠技术 ELISA 卵巢癌早期检测标记验证。 Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Apr, 2006 | Pubmed ID: 16609024 编码大鼠新生和免疫刺激分子的质粒为基础的疫苗可以引起大鼠新生非特异性免疫功能。 Molecular Cancer Therapeutics. Oct, 2003 | Pubmed ID: 14578464 切削刃: CD83 调节细胞免疫功能的发展。 Journal of Immunology (Baltimore, Md. : 1950). Mar, 2002 | Pubmed ID: 11884422 浆液性卵巢癌原位模型在免疫小鼠,为在体内肿瘤显像和肿瘤免疫反应的监测 Selene Nunez-Cruz1, Denise C. Connolly2, Nathalie Scholler1 1Penn Ovarian Cancer Research Center, Center for Research on Reproduction and Womans Health, Department of Obstetrics and Gynecology, University of Pennsylvania-School of Medicine, 2Women's Cancer Program, Fox Chase Cancer Center JoVE 2146 Immunology and Infection
浆液性卵巢癌原位模型在免疫小鼠,为在体内肿瘤显像和肿瘤免疫反应的监测 Selene Nunez-Cruz1, Denise C. Connolly2, Nathalie Scholler1 1Penn Ovarian Cancer Research Center, Center for Research on Reproduction and Womans Health, Department of Obstetrics and Gynecology, University of Pennsylvania-School of Medicine, 2Women's Cancer Program, Fox Chase Cancer Center JoVE 2146 Immunology and Infection